semaglutide and tumors GLP-1 drugs cancer: the headline is exciting. The full picture is more nuanced. New research from @ascocancer 2026 shows patients on GLP-1 medications like were up to 50% less likely Early studies suggest GLP-1s may

Clinical trials of semaglutide showed an average weight loss of about 15% over 68 weeks

Table of Contents How Retatrutide Works and Its Known Side Effects Retatrutide is an investigational triple receptor agonist targeting GLP-1, GIP, and glucagon receptors

Yin Z, Lee E-S, Ni M, Jiang H, Milatovi D, Lu R, Farina M, Rocha JBTda, Aschner M (2011) Methylmercury-induced alterations in astrocyte functions are attenuated by ebselen

[email protected]

Few potential side effects of L-carnitine supplements While L-carnitine supplements are generally considered safe for most people when taken in recommended doses, there can be some side effects